--- title: Newsroom | Drug Discovery & Development (5) description: Drug Discovery & Development | (5) --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (23)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (252)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (117)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (288)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology) - [Drug Discovery & Development (153)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (136)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) #### [GenNext unveils the world’s first fully automated protein footprinting system at the California Separation Science Society Meeting](https://news.lifesciencenewswire.com/newsroom/gennext-unveils-the-worlds-first-fully-automated-protein-footprinting-system-at-the-california-separation-science-society-meeting) September 5, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/gennext-unveils-the-worlds-first-fully-automated-protein-footprinting-system-at-the-california-separation-science-society-meeting) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/gennext-unveils-the-worlds-first-fully-automated-protein-footprinting-system-at-the-california-separation-science-society-meeting#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 5, 2023, 1:27:00 PM - [Tweet](https://twitter.com/share) Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Life Science](https://news.lifesciencenewswire.com/newsroom/tag/life-science) #### [SSI Strategy and NDA Group combine to form best-in-class global life sciences consultancy](https://news.lifesciencenewswire.com/newsroom/ssi-strategy-and-nda-group-combine-to-form-best-in-class-global-life-sciences-consultancy) August 15, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ssi-strategy-and-nda-group-combine-to-form-best-in-class-global-life-sciences-consultancy) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/ssi-strategy-and-nda-group-combine-to-form-best-in-class-global-life-sciences-consultancy#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 15, 2023, 1:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) #### [Lonza launches Nebula® Absorbance Reader for streamlined endotoxin and pyrogen testing](https://news.lifesciencenewswire.com/newsroom/lonza-launches-nebula-absorbance-reader-for-streamlined-endotoxin-and-pyrogen-testing) August 8, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/lonza-launches-nebula-absorbance-reader-for-streamlined-endotoxin-and-pyrogen-testing) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/lonza-launches-nebula-absorbance-reader-for-streamlined-endotoxin-and-pyrogen-testing#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 8, 2023, 1:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Computing & Technology](https://news.lifesciencenewswire.com/newsroom/tag/computing-it), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [iotaSciences appoints Dr. Michael Lutz as new Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/iotasciences-appoints-dr.-michael-lutz-as-new-chief-executive-officer) August 3, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/iotasciences-appoints-dr.-michael-lutz-as-new-chief-executive-officer) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/iotasciences-appoints-dr.-michael-lutz-as-new-chief-executive-officer#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 3, 2023, 2:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Life Science](https://news.lifesciencenewswire.com/newsroom/tag/life-science) #### [Titian Software enters a 3-year agreement with leading life science company](https://news.lifesciencenewswire.com/newsroom/titian-software-enters-a-3-year-agreement-with-leading-life-science-company) August 1, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/titian-software-enters-a-3-year-agreement-with-leading-life-science-company) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/titian-software-enters-a-3-year-agreement-with-leading-life-science-company#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 1, 2023, 12:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Tillotts Pharma and TVM Capital Life Science announce formation of Mage Biologics to develop innovative oral antibody therapy for ulcerative colitis](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-and-tvm-capital-life-science-announce-formation-of-mage-biologics-to-develop-innovative-oral-antibody-therapy-for-ulcerative-colitis) July 20, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-and-tvm-capital-life-science-announce-formation-of-mage-biologics-to-develop-innovative-oral-antibody-therapy-for-ulcerative-colitis) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-and-tvm-capital-life-science-announce-formation-of-mage-biologics-to-develop-innovative-oral-antibody-therapy-for-ulcerative-colitis#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 20, 2023, 1:18:59 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) #### [PromoCell Launches PromoExQ MSC Growth Medium XF for GMP Compliant Long-term Expansion of Mesenchymal Stem Cells](https://news.lifesciencenewswire.com/newsroom/promocell-launches-promoexq-msc-growth-medium-xf-for-gmp-compliant-long-term-expansion-of-mesenchymal-stem-cells) July 19, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/promocell-launches-promoexq-msc-growth-medium-xf-for-gmp-compliant-long-term-expansion-of-mesenchymal-stem-cells) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/promocell-launches-promoexq-msc-growth-medium-xf-for-gmp-compliant-long-term-expansion-of-mesenchymal-stem-cells#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 19, 2023, 5:51:57 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) #### [PrecisionLife identifies first detailed genetic risk factors for long COVID and common mechanisms with ME/CFS and other complex diseases](https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases) July 18, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 18, 2023, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [clinical research](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) #### [VitaDAO launches VITA-FAST tokens, revolutionizing governance in longevity research](https://news.lifesciencenewswire.com/newsroom/vitadao-launches-vita-fast-tokens-revolutionizing-governance-in-longevity-research) June 30, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/vitadao-launches-vita-fast-tokens-revolutionizing-governance-in-longevity-research) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/vitadao-launches-vita-fast-tokens-revolutionizing-governance-in-longevity-research#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 30, 2023, 1:30:00 PM - [Tweet](https://twitter.com/share) [Previous](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development/page/4) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development/page/6) ##### Browse more news ## Recent releases #### [Ceryx Medical manufactures first implantable heart failure device at King’s College London’s MAISI f...](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility) October 22, 2026 A first for both organisations: the first implantable device built by the UK’s national active implant manufacturing facility is Ceryx’s bioelectronic... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility) #### [Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) October 6, 2026 Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) #### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) October 5, 2026 Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)